גמסיטאבין טבע ® 1000 מ"ג/ויאל

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

GEMCITABINE AS HYDROCHLORIDE 1000 MG/VIAL

Disponible desde:

SALOMON,LEVIN & ELSTEIN LTD

Código ATC:

L01BC05

formulario farmacéutico:

POWDER FOR SOLUTION FOR INJECTION

Vía de administración:

I.V

Fabricado por:

LEMERY S.A. DE C.V. MEXICO

Grupo terapéutico:

GEMCITABINE

indicaciones terapéuticas:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Fecha de autorización:

2010-04-01